Vanta Bioscience Limited (VANTABIO.BO)

INR 20.76

(-4.99%)

EBITDA Summary of Vanta Bioscience Limited

  • Vanta Bioscience Limited's latest annual EBITDA in 2023 was 14.19 Million INR , up 154.85% from previous year.
  • Vanta Bioscience Limited's latest quarterly EBITDA in 2023 FY was N/A , up 154.85% from previous quarter.
  • Vanta Bioscience Limited reported an annual EBITDA of -17.06 Million INR in 2022, down -169.02% from previous year.
  • Vanta Bioscience Limited reported an annual EBITDA of 38.91 Million INR in 2021, down -13.28% from previous year.
  • Vanta Bioscience Limited reported a quarterly EBITDA of 20.64 Million INR for 2023 Q2, up 211.82% from previous quarter.
  • Vanta Bioscience Limited reported a quarterly EBITDA of -7.51 Million INR for 2023 Q4, down -136.4% from previous quarter.

Annual EBITDA Chart of Vanta Bioscience Limited (2023 - 2017)

Created with Highcharts 11.1.0YearsEBITDA2017201820192020202120222023-40000000 INR-20000000 INR0 INR20000000 INR40000000 INR60000000 INR

Historical Annual EBITDA of Vanta Bioscience Limited (2023 - 2017)

Year EBITDA EBITDA Growth
2023 14.19 Million INR 154.85%
2022 -17.06 Million INR -169.02%
2021 38.91 Million INR -13.28%
2020 39.72 Million INR -8.46%
2019 44.79 Million INR 17.25%
2018 35.02 Million INR 232.03%
2017 10.83 Million INR 0.0%

Peer EBITDA Comparison of Vanta Bioscience Limited

Name EBITDA EBITDA Difference
Alfavision Overseas (India) Limited 10.12 Million INR -40.172%
Biocon Limited 41.52 Billion INR 99.966%
Blue Jet Healthcare Limited 2.29 Billion INR 99.381%
Concord Biotech Limited 4.65 Billion INR 99.695%
Dishman Carbogen Amcis Limited 3.07 Billion INR 99.538%
FERMENTA BIOTECH LIMITED 262.68 Million INR 94.598%
GENOMIC VALLEY BIOTECH LIMITED 147.4 Thousand INR -9527.413%
Lyka Labs Limited 167.58 Million INR 91.532%
Panacea Biotec Limited -200.6 Million INR 107.074%
SAMSRITA LABS LIMITED -2.46 Million INR 676.764%
Servoteach Industries Limited - INR -Infinity%
SMS Lifesciences India Limited 349.41 Million INR 95.939%
Supriya Lifescience Limited 1.83 Billion INR 99.227%
Syngene International Limited 10.84 Billion INR 99.869%
TAKE Solutions Limited -1.05 Billion INR 101.35%
Titan Biotech Limited 360.29 Million INR 96.061%
Transgene Biotek Limited -4.33 Million INR 427.057%